
    
      This clinical study is a prospective, single-center, single-arm, open-label, pilot study to
      evaluate the safety and tolerability of the R:GEN Laser System and to collect information on
      the severity of AMD in subjects with bilateral large drusen. All participants will receive
      the intervention at the baseline visit and at the 24-week visit. All participants will be
      evaluated at 24 and 48 weeks from the baseline visit.
    
  